World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
30351
World Ranking
9390
National Ranking
4843

Michael P. Link publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael P. Link sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 256 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael P. Link D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael P. Link sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michael P. Link is affiliated with Stanford University in the United States. Their research spans a range of topics primarily within medicine, with a strong focus on pathology, pediatrics, cancer research, and related subfields.

The main fields of study for Michael P. Link include Medicine, with specific subfields in Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine, Cancer Research, and Radiology, Nuclear Medicine and Imaging.

Key topics covered in their research are:

  • Lymphoma Diagnosis and Treatment
  • Childhood Cancer Survivors' Quality of Life
  • Genetic factors in colorectal cancer
  • Cancer Genomics and Diagnostics
  • Lung Cancer Treatments and Mutations
  • Acute Lymphoblastic Leukemia research
  • Viral-associated cancers and disorders

Frequent co-authors who have collaborated with Michael P. Link include:

  • Jamie E. Flerlage
  • Lianna J. Marks
  • Alison M. Friedmann
  • Ranjana H. Advani
  • Angela M. Feraco

Michael P. Link has published extensively in several scientific journals. The most frequent venues of their publications are:

  • Blood
  • Hematological Oncology
  • Journal of Clinical Oncology
  • Pediatric Blood & Cancer
  • Genetics in Medicine

Recent significant papers by Michael P. Link include the following:

  • "The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee" (2022), published in Blood
  • "Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation" (2021), published in Genetics in Medicine
  • "Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation" (2022), published in Genetics in Medicine
  • "Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology" (2023), published in Journal of the National Comprehensive Cancer Network
  • "Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance" (2021), published in Journal of Clinical Oncology

Best Publications

  • The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the Extremity

    M P Link;A M Goorin;A W Miser;A A Green

  • Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

    Holcombe E Grier;Mark D Krailo;Nancy J Tarbell;Michael P Link

  • Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.

    M Smith;D Arthur;B Camitta;A J Carroll

  • Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

    Paul A. Meyers;Cindy L. Schwartz;Mark D. Krailo;John H. Healey

  • Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

    Paul A. Meyers;Cindy L. Schwartz;Mark Krailo;Eugenie S. Kleinerman

  • National Institutes of Health State-of-the-Science Conference Statement: Symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002.

    Patrick Dl;Ferketich Sl;Frame Ps;Harris Jj

  • Prognostic Factors and Clinical Outcomes in Children and Adolescents With Metastatic Rhabdomyosarcoma—A Report From the Intergroup Rhabdomyosarcoma Study IV

    John C. Breneman;Elizabeth Lyden;Alberto S. Pappo;Michael P. Link

  • Presurgical Chemotherapy Compared With Immediate Surgery and Adjuvant Chemotherapy for Nonmetastatic Osteosarcoma: Pediatric Oncology Group Study POG-8651

    Allen M. Goorin;Douglas J. Schwartzentruber;Meenakshi Devidas;Mark C. Gebhardt

  • Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study.

    M D Amylon;J Shuster;J Pullen;C Berard

  • National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002.

    Donald L. Patrick;Jürgen Unützer

  • Attitudes and Practices Among Pediatric Oncologists Regarding End-of-Life Care: Results of the 1998 American Society of Clinical Oncology Survey

    Joanne M. Hilden;Ezekiel J. Emanuel;Diane L. Fairclough;Michael P. Link

  • Monoclonal Antibody and Enzymatic Profiles of Human Malignant T-Lymphoid Cells and Derived Cell Lines

    Stephen D. Smith;Margaret Shatsky;Pamela S. Cohen;Roger Wamke

  • Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study.

    Michael P. Link;Allen M. Goorin;Marc Horowitz;William H. Meyer

  • Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study

    W Crist;A Carroll;J Shuster;J Jackson

  • The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols.

    R. Beverly Raney;Harold M. Maurer;James R. Anderson;Richard J. Andrassy

  • The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias

    Stephen P. Hunger;Naomi Galili;Andrew J. Carroll;William M. Crist

  • Thyroid dysfunction after radiotherapy in children with Hodgkin's disease.

    Louis S. Constine;Sarah S. Donaldson;I. Ross McDougall;Richard S. Cox

  • Phase II/III Trial of Etoposide and High-Dose Ifosfamide in Newly Diagnosed Metastatic Osteosarcoma: A Pediatric Oncology Group Trial

    Allen M. Goorin;Michael B. Harris;Mark Bernstein;William Ferguson

  • Adolescent and young adult oncology. Clinical practice guidelines in oncology.

    Peter F. Coccia;Jessica Altman;Smita Bhatia;Scott C. Borinstein

  • A multidisciplinary study investigating radiotherapy in Ewing’s sarcoma: end results of POG #8346

    Sarah S Donaldson;Margaret Torrey;Michael P Link;Arvin Glicksman

Frequent Co-Authors

Sarah S. Donaldson
Sarah S. Donaldson Stanford University
Jonathan J. Shuster
Jonathan J. Shuster University of Florida
Holcombe E. Grier
Holcombe E. Grier Harvard University
William M. Crist
William M. Crist University of Oklahoma
Howard J. Weinstein
Howard J. Weinstein Harvard University
Bruce M. Camitta
Bruce M. Camitta Medical College of Wisconsin
Nancy J. Tarbell
Nancy J. Tarbell Harvard University
Mark C. Gebhardt
Mark C. Gebhardt Harvard Medical School
Roger A. Warnke
Roger A. Warnke Stanford University
Michael L. Cleary
Michael L. Cleary Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the US doesn't just mean pursuing an MD. Numerous online degrees and accelerated programs offer flexible routes into healthcare. For registered nurses aiming to advance their careers, online DNP programs can provide a pathway to clinical leadership or specialized practices while balancing work and life commitments.

If you're looking for a faster entry into patient care, a 6 month lpn program online offers a swift transition to a Licensed Practical Nurse role, helping you start gaining experience and earning credentials quickly.

For those already holding a BSN degree, bsn to np programs online enable nurses to specialize and move into advanced practice roles, including psychiatric mental health, with the convenience of remote learning.

Not every healthcare professional works directly with patients. For aspiring healthcare leaders or administrators, online healthcare administration programs can open doors to vital management roles in hospitals, clinics, and other health organizations. These versatile pathways allow you to shape your medical career to fit your goals and lifestyle.

Best Scientists Citing Michael P. Link

Trending Scientists

Recently Published Articles